Marker Therapeutics, Inc.MRKRNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P0
Near historical low
vs 3Y Ago
-25046426.5x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -439130580.12% |
| Q3 2025 | -45.65% |
| Q2 2025 | 65.85% |
| Q1 2025 | -16.94% |
| Q4 2024 | -492.75% |
| Q3 2024 | 133.57% |
| Q2 2024 | 7.02% |
| Q1 2024 | -62.07% |
| Q4 2023 | -109.99% |
| Q3 2023 | 84.02% |
| Q2 2023 | -19.84% |
| Q1 2023 | 6.62% |
| Q4 2022 | 17.53% |
| Q3 2022 | -862.11% |
| Q2 2022 | 93.50% |
| Q1 2022 | -151.66% |
| Q4 2021 | 25.44% |
| Q3 2021 | 5.71% |
| Q2 2021 | 23.19% |
| Q1 2021 | -44.66% |
| Q4 2020 | -46.69% |
| Q3 2020 | 2.58% |
| Q2 2020 | -7.45% |
| Q1 2020 | 11.20% |
| Q4 2019 | 19.47% |
| Q3 2019 | -35.52% |
| Q2 2019 | -7.71% |
| Q1 2019 | 37.04% |
| Q4 2018 | -72.54% |
| Q3 2018 | -48.87% |
| Q2 2018 | -2.25% |
| Q1 2018 | 5.33% |
| Q4 2017 | -22.37% |
| Q3 2017 | -0.67% |
| Q2 2017 | -4.59% |
| Q1 2017 | -9.70% |
| Q4 2016 | 11.09% |
| Q3 2016 | -0.93% |
| Q2 2016 | -135.51% |
| Q1 2016 | 2.49% |